NCT03047070View on ClinicalTrials.gov

Lidocaine in ERAS for FESS

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 9, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Intraoperative Bleeding
Interventions
DRUG

Lidocaine

IV Lidocaine infusion

DRUG

Normal saline

IV normal saline infusion

Trial Locations (2)

71111

Faculty of Medicine Assuit University, Asyut

Seham Mohamed Moeen Ibrahim, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03047070 - Lidocaine in ERAS for FESS | Biotech Hunter | Biotech Hunter